Targeting the Microbiome: New Frontiers in Drug Development and Therapeutic Strategies

Abstract

The human microbiome, a vast community of microorganisms residing within and on the

human body, has emerged as a critical player in health and disease. This paper explores the

growing field of microbiome-based drug development and therapeutic strategies, highlighting

the potential for microbiome-targeted interventions in treating a variety of conditions. We

review the key mechanisms through which the microbiome influences human health, the

emerging tools and technologies that enable microbiome modulation, and the challenges and

opportunities in translating microbiome science into clinical practice. The paper concludes

with an outlook on the future of microbiome-based therapeutics and the need for continued

research to harness its full potential.